Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal, Phase III Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System (System Version 1.5) in Epilepsy Patients

NCT02371200 is registered in ClinicalTrials.gov with Brain Sentinel as lead sponsor.

NCT NCT02371200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02371200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal, Phase III Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System (System Version 1.5) in Epilepsy Patients
Lead sponsor
Brain Sentinel
Phase
Observational
Overall status
Completed
Start date
April 30, 2015
Completion date
February 28, 2018
Enrollment
13 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, generalized tonic-clonic seizures